In case of equivalent degree of the decrease in LDL-C levels , @-week combination therapy with atorvastatin and ezetimibe , unlike rosuvastatin treatment , induced increases in basal glycemia , insulinemia , HbA@c , and HOMA-IR index irrespective of the presence of carbohydrate metabolism disturbances before treatment .